US Stock MarketDetailed Quotes
QLGN Qualigen Therapeutics
- 4.8310
- +0.4110+9.30%
Close Nov 22 16:00 ET
- 5.0400
- +0.2090+4.33%
Post 19:10 ET
3.56MMarket Cap-100P/E (TTM)
5.0000High4.3434Low137.94KVolume4.4500Open4.4200Pre Close651.04KTurnover18.74%Turnover RatioLossP/E (Static)736.43KShares39.130052wk High-1.66P/B3.56MFloat Cap3.335852wk Low--Dividend TTM735.99KShs Float687487.5000Historical High--Div YieldTTM14.86%Amplitude3.3350Historical Low4.7190Avg Price1Lot Size
Qualigen Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -54.34%1.27M | -51.67%1.74M | -46.37%1.42M | -23.41%11.3M | -33.83%2.27M | -19.93%2.78M | -19.46%3.6M | -45.92%2.65M | -38.46%14.76M | -29.99%3.44M |
| Selling and administrative expenses | -14.33%1.15M | -59.35%986.48K | -22.76%1.06M | -40.67%6.1M | -62.52%962.77K | -47.36%1.34M | -18.17%2.43M | -54.92%1.37M | -16.25%10.27M | -21.75%2.57M |
| -General and administrative expense | -14.33%1.15M | -59.35%986.48K | -22.76%1.06M | -40.67%6.1M | -62.52%962.77K | -47.36%1.34M | -8.79%2.43M | -52.77%1.37M | -12.37%10.27M | -18.26%2.57M |
| Research and development costs | -91.44%123.43K | -35.79%754.29K | -71.57%364.39K | 16.12%5.21M | 51.11%1.31M | 54.92%1.44M | -22.01%1.17M | -31.26%1.28M | -61.71%4.49M | -46.62%867.69K |
| Operating profit | 54.34%-1.27M | 51.67%-1.74M | 46.37%-1.42M | 23.41%-11.3M | 33.83%-2.27M | 19.93%-2.78M | 13.03%-3.6M | 47.08%-2.65M | 34.87%-14.76M | 26.06%-3.44M |
| Net non-operating interest income expense | 1.90%-360.28K | 30.17%-263.56K | 74.91%-136.56K | -4,332.72%-1.52M | -370.12%-235.81K | -8,030.40%-367.26K | -7,923.71%-377.42K | -8,726.38%-544.24K | -180.57%-34.4K | -960.38%-50.16K |
| Non-operating interest income | --48.08K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 11.19%408.36K | -30.17%263.56K | -74.91%136.56K | 4,332.72%1.52M | --235.81K | --367.26K | --377.42K | --544.24K | --34.4K | ---- |
| Other net income (expense) | -87.24%-167.4K | 18.12%526.56K | -1,124.06%-472.66K | -61.44%349.78K | 133.37%37.42K | -127.83%-89.41K | 2,990.70%445.8K | -105.65%-38.61K | -80.81%907.2K | -126.32%-112.14K |
| Gain on sale of security | -389.02%-494.46K | 14.31%503.32K | -97.00%31.2K | 124.37%2.04M | 686.43%657.61K | -131.47%-101.11K | 2,874.96%440.29K | 52.02%1.04M | -80.79%907.2K | -126.44%-112.14K |
| Special income (charges) | -27.79%-27.79K | --22.15K | 86.34%-147.2K | ---1.72M | ---625.65K | ---21.75K | --0 | ---1.08M | --0 | --0 |
| -Less:Other special charges | --27.79K | ---22.15K | -86.34%147.2K | --1.7M | --625.65K | ---- | ---- | --1.08M | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | ---- | ---- | ---21.75K | --0 | ---21.75K | ---- | ---- | --0 | --0 |
| Other non- operating income (expenses) | 960.72%354.85K | -80.14%1.09K | ---356.66K | --38.99K | --5.46K | --33.45K | 1,565.16%5.51K | ---- | ---- | ---- |
| Income before tax | 44.47%-1.8M | 58.18%-1.48M | 37.19%-2.03M | 10.14%-12.48M | 31.30%-2.47M | -2.90%-3.24M | 14.28%-3.53M | 25.13%-3.23M | 22.38%-13.89M | 14.63%-3.6M |
| Income tax | -2.2K | -130.03%-1.21K | 28.21%1.79K | -173.20%-4.79K | -1,378.13%-4.79K | 0 | -25.78%4.04K | 89.27%1.39K | 20.66%6.55K | -88.57%375 |
| Net income | 51.45%-1.79M | 55.05%-1.58M | 50.51%-2.03M | 34.58%-13.76M | 71.28%-2.45M | 8.90%-3.7M | 15.02%-3.51M | 4.92%-4.11M | -17.53%-21.03M | -102.22%-8.53M |
| Net income continuous Operations | 44.54%-1.79M | 58.26%-1.48M | 37.16%-2.03M | 10.22%-12.48M | 31.44%-2.47M | -2.90%-3.24M | 14.30%-3.54M | 25.11%-3.24M | 22.36%-13.89M | 14.69%-3.6M |
| Net income discontinuous operations | --0 | -437.02%-100K | --0 | 82.00%-1.29M | 100.35%17.31K | 49.55%-460.04K | --29.67K | ---872.19K | ---7.14M | ---4.93M |
| Minority interest income | 0 | 0 | 0 | 85.67%-343.04K | 0 | 83.31%-38.53K | -956.46%-43.48K | -261.03K | -2.39M | -2.16M |
| Net income attributable to the parent company | 50.94%-1.79M | 54.49%-1.58M | 47.15%-2.03M | 28.02%-13.42M | 61.55%-2.45M | 4.41%-3.66M | 15.99%-3.46M | 10.96%-3.85M | -4.15%-18.64M | -51.04%-6.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 27.59K | 0 | 60.02K | 0 | 0 | 0 | ||||
| Net income attributable to common stockholders | 50.18%-1.82M | 54.49%-1.58M | 45.59%-2.09M | 28.02%-13.42M | 61.55%-2.45M | 4.41%-3.66M | 15.99%-3.46M | 10.96%-3.85M | -4.15%-18.64M | -51.04%-6.37M |
| Basic earnings per share | 87.01%-235 | 69.57%-10.5 | 54.55%-17.5 | 45.47%-132.5 | 70.71%-22.8478 | -3,629.90%-1.81K | 38.39%-34.5 | 36.89%-38.5 | 20.33%-243 | -20.00%-78 |
| Diluted earnings per share | 87.01%-235 | 69.57%-10.5 | 54.55%-17.5 | 45.47%-132.5 | 70.71%-22.8478 | -3,629.90%-1.81K | 38.39%-34.5 | 36.89%-38.5 | 20.33%-243 | -20.00%-78 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data